Turn Therapeutics Inc.
TTRX
$6.93
$0.111.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 974.50K | 496.90K | -- | -- | -- |
| Gross Profit | -974.50K | -496.90K | -- | -- | -- |
| SG&A Expenses | 6.35M | 5.59M | 3.75M | 2.52M | 1.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.69M | 6.36M | 3.99M | 2.75M | 1.75M |
| Operating Income | -7.69M | -6.36M | -3.99M | -2.75M | -1.75M |
| Income Before Tax | -3.84M | -3.19M | -3.80M | -2.56M | -1.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.84 | -3.19 | -3.80 | -2.56 | -1.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.84M | -3.19M | -3.80M | -2.56M | -1.67M |
| EBIT | -7.69M | -6.36M | -3.99M | -2.75M | -1.75M |
| EBITDA | -7.64M | -6.30M | -3.94M | -2.70M | -1.70M |
| EPS Basic | -0.14 | -0.12 | -0.14 | -0.09 | -0.06 |
| Normalized Basic EPS | -0.09 | -0.07 | -0.09 | -0.06 | -0.04 |
| EPS Diluted | -0.14 | -0.12 | -0.14 | -0.09 | -0.06 |
| Normalized Diluted EPS | -0.09 | -0.07 | -0.09 | -0.06 | -0.04 |
| Average Basic Shares Outstanding | 113.37M | 110.85M | 109.35M | 108.02M | 107.03M |
| Average Diluted Shares Outstanding | 113.37M | 110.85M | 109.35M | 108.02M | 107.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |